The Biden administration announced last week that it will recommend a third “booster” shot for Americans who have received either of the mRNA COVID-19 vaccines currently authorized for emergency use. (A recommendation for the viral vector shot developed by Johnson & Johnson, which is also available on an emergency basis in the U.S. market, will be provided at a later time, after data from its ongoing two-dose trial is assessed.) The prospect of hundreds of millions of third mRNA doses going into the arms of Americans before much of the world gets a first inoculation always was a possibility, but the recommendation to move forward came more quickly, and is broader in its reach, than many had expected.
Want to see more of The Dispatch in Google search?
Add Us as a Preferred Source



